KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Clorox (CLX) over the last 15 years, with Sep 2025 value amounting to -$59.0 million.

  • Clorox's Cash from Financing Activities rose 75.11% to -$59.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$746.0 million, marking a year-over-year increase of 28.75%. This contributed to the annual value of -$924.0 million for FY2025, which is 41.07% down from last year.
  • According to the latest figures from Q3 2025, Clorox's Cash from Financing Activities is -$59.0 million, which was up 78.85% from -$279.0 million recorded in Q2 2025.
  • In the past 5 years, Clorox's Cash from Financing Activities ranged from a high of $155.0 million in Q3 2023 and a low of -$447.0 million during Q2 2021.
  • Over the past 3 years, Clorox's median Cash from Financing Activities value was -$237.0 million (recorded in 2024), while the average stood at -$188.7 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 645.45% in 2021, then surged by 542.86% in 2023.
  • Clorox's Cash from Financing Activities (Quarterly) stood at -$143.0 million in 2021, then tumbled by 95.80% to -$280.0 million in 2022, then rose by 7.50% to -$259.0 million in 2023, then surged by 57.92% to -$109.0 million in 2024, then spiked by 75.11% to -$59.0 million in 2025.
  • Its Cash from Financing Activities stands at -$59.0 million for Q3 2025, versus -$279.0 million for Q2 2025 and -$299.0 million for Q1 2025.